Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Income Tax Expense Over TimeExpanding
Percentile Rank77
3Y CAGR+80.6%
Studio
Year-over-Year Change

Income taxes paid or accrued

3Y CAGR
+80.6%/yr
Annual compound
Percentile
P77
Within normal range
vs 3Y Ago
5.9x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$165000.00+44.7%
2024$114000.00+714.3%
2023$14000.00-50.0%
2022$28000.00+114.3%
2021$-196000.00+93.0%
2020$-2.79M-1096.4%
2019$280316.00+926.6%
2018$-33910.00-101.7%
2017$1.97M+440.0%
2016$364144.00-